AOD 9604 Pre-mixed Pen 5mg

£100.00

AOD 9604 Anti-Obesity Drug 9604

AOD 9604 is a synthetic 16-amino acid peptide fragment derived from the C-terminal region of human growth hormone (hGH). It was developed specifically for its lipolytic (fat-burning) properties while eliminating the growth-promoting and insulin-like effects of full-length growth hormone.

Key Characteristics:

  • Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (corresponding to hGH residues 177-191 with a tyrosine addition at the N-terminus)

  • Mechanism: Stimulates lipolysis and inhibits lipogenesis in adipose tissue without activating the full growth hormone receptor or significantly raising IGF-1 levels

  • Properties: Highly selective for fat metabolism; does not promote linear growth or cause insulin resistance

  • Half-life: Short (approximately 1–2 hours)

Research Applications:

  • Fat reduction and body composition studies

  • Obesity and metabolic syndrome research

  • Lipolysis and adipose tissue metabolism investigations

  • Comparison with full-length hGH and HGH Fragment 176-191

  • Non-growth hormone-mediated weight loss models

AOD 9604 is one of the most studied fragments of human growth hormone for its ability to promote fat breakdown (especially visceral and abdominal fat) while avoiding the broader anabolic or diabetogenic effects associated with intact hGH.

For laboratory research use only. Not intended for human or veterinary use.

AOD 9604 Anti-Obesity Drug 9604

AOD 9604 is a synthetic 16-amino acid peptide fragment derived from the C-terminal region of human growth hormone (hGH). It was developed specifically for its lipolytic (fat-burning) properties while eliminating the growth-promoting and insulin-like effects of full-length growth hormone.

Key Characteristics:

  • Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (corresponding to hGH residues 177-191 with a tyrosine addition at the N-terminus)

  • Mechanism: Stimulates lipolysis and inhibits lipogenesis in adipose tissue without activating the full growth hormone receptor or significantly raising IGF-1 levels

  • Properties: Highly selective for fat metabolism; does not promote linear growth or cause insulin resistance

  • Half-life: Short (approximately 1–2 hours)

Research Applications:

  • Fat reduction and body composition studies

  • Obesity and metabolic syndrome research

  • Lipolysis and adipose tissue metabolism investigations

  • Comparison with full-length hGH and HGH Fragment 176-191

  • Non-growth hormone-mediated weight loss models

AOD 9604 is one of the most studied fragments of human growth hormone for its ability to promote fat breakdown (especially visceral and abdominal fat) while avoiding the broader anabolic or diabetogenic effects associated with intact hGH.

For laboratory research use only. Not intended for human or veterinary use.